title: Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial.
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.forename: C
authors.initials: C
authors.lastname: Hulin
authors.forename: G
authors.initials: G
authors.lastname: Marit
authors.forename: D
authors.initials: D
authors.lastname: Caillot
authors.forename: T
authors.initials: T
authors.lastname: Facon
authors.forename: P
authors.initials: P
authors.lastname: Lenain
authors.forename: C
authors.initials: C
authors.lastname: Berthou
authors.forename: B
authors.initials: B
authors.lastname: Pégourié
authors.forename: A M
authors.initials: AM
authors.lastname: Stoppa
authors.forename: P
authors.initials: P
authors.lastname: Casassus
authors.forename: M
authors.initials: M
authors.lastname: Michallet
authors.forename: L
authors.initials: L
authors.lastname: Benboubker
authors.forename: H
authors.initials: H
authors.lastname: Maisonneuve
authors.forename: C
authors.initials: C
authors.lastname: Doyen
authors.forename: S
authors.initials: S
authors.lastname: Leyvraz
authors.forename: C
authors.initials: C
authors.lastname: Mathiot
authors.forename: H
authors.initials: H
authors.lastname: Avet-Loiseau
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: J L
authors.initials: JL
authors.lastname: Harousseau
mesh_terms: D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019650:Hematopoietic Stem Cell Mobilization; D006412:Hematopoietic Stem Cells; D006801:Humans; D007937:Leukapheresis / Q000379:methods*; D009101:Multiple Myeloma / Q000628:therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone